This session will assess the differences in the quality of clinical trials on the use of skin substitutes in chronic wounds, specifically focusing on the importance of identifying inherent bias in clinical study design in the age of evidence-based medicine. This symposium will also include an overview of the recent Agency for Healthcare Research & Quality (AHRQ) 2020 Technical Assessment on Skin Substitutes document and include a brief review of the MiMedx clinical studies that were evaluated in the ARHQ document.

REGISTER HERE

Speakers
Frances L. Game BSc(Hons), MBBCh(Hons), FRCP
Consultant Diabetologist and Director of R&D
Derbyshire, England, UK

 

 

 

 

 

 

William H. Tettelbach, MD, FACP, FIDSA, FUHM, CWS
Associate Chief Medical Officer MiMedx

 

 

 

 

 

 

 

 

This webinar program is sponsored by: